Key Market Overview:
Life Science Analytics Market size was worth USD 22.3 Billion in 2022, accounting for a CAGR growth of 11.5% during the forecast period (2023-2030), and the market is estimated to be valued at USD 48.1 Billion by 2030.
Life science analytics is the application of data analytics, machine learning, and other advanced analytical techniques to study and gain insights from various biological and health-related data sets. This field involves analyzing large sets of data generated from various life science sources, such as genomic data, medical records, clinical trials, and patient outcomes. By applying advanced analytics techniques to these datasets, life science analytics help uncover patterns, identify correlations, and gain insights that aid in the development of new drugs, treatments, and therapies for various diseases and conditions. Furthermore, the market for life science analytics is a growing owing to the increasing amount of data generated in the life sciences.
Many companies are focusing on research and development to introduce new products in the life science analytics market to provide innovative solutions to the evolving needs of the healthcare industry. For instance, in March 2022, IQVIA launched OCE+, the latest addition to its life science customer engagement platform. OCE+ features Next Best, an AI-powered recommendation engine that provides daily recommendations for engaging healthcare professionals, improving productivity and ROI. This in turn, has propelled the growth of the life science analytics market. Geographically, Asia Pacific is expected to witness fastest growth rate during the forecast period owing to the growing trend of outsourcing clinical trials and research activities. Additionally, the rising prevalence of chronic diseases and the need for personalized medicine are also driving the growth of the life science analytics market in the region.
Market Dynamics:
Driver:
- The healthcare industry is undergoing a digital transformation, with increasing demand for advanced technologies such as big data analytics, artificial intelligence, and machine learning. This increasing demand for advanced healthcare technologies is driving market growth.
- With the rise of precision medicine, there is a growing need for data-driven insights to develop targeted therapies and treatment plans for individual patients. Hence, driving the market of life science analytics.
Restraint:
Implementing life science analytics solutions is expensive, particularly for smaller healthcare providers. This is a major barrier for small and medium-sized hospitals that do not have the budget to invest in these systems. Hence, the market growth is restricted due to high implementation costs. Furthermore, healthcare data is highly sensitive and subject to regulatory requirements, which makes it difficult for healthcare providers to share data and leverage analytics solutions. Thus, data security and privacy concerns restrict market growth.
Opportunities:
The increasing advancements in artificial intelligence and machine learning provide a significant opportunity for the life science analytics market. The development of more advanced AI and machine learning algorithms will help healthcare providers gain deeper insights into patient data, leading to more personalized and effective treatments. This will improve patient outcomes, reduce costs, and enhance the overall quality of healthcare services.
Life Science Analytics Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2017-2030 |
| Market Size in 2030 (USD Billion) | 48.1 Billion |
| CAGR (2023-2030) | 11.5 % |
| By Type of Analytics | Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics. |
| By Component | Software, Services, and Hardware |
| By Deployment Type | Cloud-Based, On-Premise, and Hybrid |
| By Application | Drug Discovery, Clinical Trials, Precision Medicine, Regulatory Compliance, Post-Market Surveillance, Pharmacovigilance, Regulatory Compliance, R&D Activities, Supply Chain Optimization, and Others. |
| By End-User | Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutions, and Government Agencies. |
| By Geography | North America, Europe, Asia Pacific, Latin America, and Middle East, and Africa |
| Key Players | Accenture, IBM Corporation, Oracle Corporation, IQVIA, SAS Institute Inc., Allscripts Healthcare, LLC, Cerner Corporation, CitiusTech Inc., Health Catalyst, and McKesson Corporation |
Market Segmentation:
By Type of Analytics
The type of analytics segment is categorized into descriptive analytics, predictive analytics, and prescriptive analytics. In 2022, the descriptive analytics segment accounted for the highest share in the market as it provides insights into historical data, which is essential for understanding trends, patterns, and other important information. Descriptive analytics also helps companies to monitor key performance indicators (KPIs) and track progress over time. Hence, these factors also contribute to segment growth.
Moreover, the predictive analytics segment is expected to witness significant growth due to its use of advanced algorithms and machine learning techniques to analyze data and identify patterns that are used to make predictions about future outcomes.
By Component
The component segment is classified into software, services, and hardware. The software segment accounted for the highest share in the market as is the primary tool used for analyzing and processing large volumes of data generated in the life sciences industry.
Moreover, the services provide expertise in the implementation and use of life science analytics software. Many companies are increasingly looking for third-party service providers to help them integrate and manage their analytics solutions. Hence, the service segment is expected to witness significant growth during the forecast period.
By Deployment Type
The deployment type segment is categorized into cloud-based, on-premise, and hybrid. On-premise deployment segment dominated with the highest share in the market as it offers more control and customization options to the end-users, as the software and infrastructure are managed locally. Many life science organizations prefer to keep their data and analytics systems in-house, rather than relying on cloud-based solutions or a hybrid approach which is also contributing to the segment growth.
Moreover, the cloud-based segment is expected to witness significant growth during the forecast period as cloud-based solutions offer a variety of benefits such as scalability, flexibility, and accessibility with an internet connection, making them an attractive option for many life science organizations.
By Application
The application segment is divided into drug discovery, clinical trials, precision medicine, regulatory compliance, post-market surveillance, pharmacovigilance, regulatory compliance, R&D activities, supply chain optimization, and others. In 2022, the clinical trials application accounted for the highest share in the life science analytics market as it enables better patient stratification, improved trial design, and enhanced operational efficiency. Furthermore, clinical trials enable to accelerate drug development and reduce costs which are the major factors contributing to segment growth.
Moreover, precision medicine application is expected to witness significant growth driven by the growing trend towards personalized medicine and the increasing use of genomics and other molecular data to develop targeted therapies.
By End-User
The end user segment is classified into pharmaceutical and biotechnology companies, contract research organizations (CROs), academic research institutions, and government agencies. Pharmaceutical and biotechnology companies accounted for the highest share in the life science analytics market. This is driven by their large share in drug development and manufacturing, as well as their need for advanced analytics solutions to improve efficiency and reduce costs in R&D activities.
Moreover, contract research organizations (CROs) are expected to witness significant growth over the forecast period due to the increasing outsourcing of clinical trials and R&D activities to specialized service providers. Additionally, the increasing trend towards personalized or precision medicine is also expected to boost demand for life science analytics solutions among contract research organizations.
By Region
The region includes North America, Europe, Asia Pacific, Latin America, and Middle East, and Africa. North America accounted for the highest share in the life science analytics market in 2022. The growth in North America is attributed to the presence of established life sciences companies, early adoption of advanced technologies, and favorable government initiatives.
Moreover, the Asia Pacific region is expected to be the fastest-growing region in the market during the forecast period due to the increasing focus on R&D activities and outsourcing, and the growing demand for personalized medicine.
Life Science Analytics Market Competitive Landscape:
The life science analytics market is highly competitive and includes many players. The players are focusing on developing advanced and innovative solutions to gain a competitive advantage. Mergers and acquisitions, partnerships, and collaborations are also common strategies adopted by players to expand their market share and enhance their product offerings. The key players in the market include-
- Accenture
- IBM Corporation
- Oracle Corporation
- IQVIA
- SAS Institute Inc.
- Allscripts Healthcare, LLC
- Cerner Corporation
- CitiusTech Inc.
- Health Catalyst
- McKesson Corporation
Recent Developments:
- In August 2021, Illumina announced the acquisition of GRAIL, a company that specializes in developing blood tests for early cancer detection. The acquisition is expected to strengthen Illumina’s position in the growing field of liquid biopsy and cancer diagnostics.
- In September 2021, PerkinElmer announced the acquisition of BioLegend, a provider of antibodies and reagents for research use. The acquisition is expected to expand PerkinElmer’s product offerings in the life science research market.
- In February 2023, Bayer acquired Blackford, a global imaging AI platform and solutions provider, to integrate AI-powered imaging analysis tools into clinical trials and improve patient outcomes.
Table of Content
To check our Table of Contents, please mail us at: [email protected]
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.